1
Return

The precision strategy of human genome correction via a set of circular donor DNA and its cleaver

delete2026-03-12
delete0
delete
OA
AI
K
KK Kohji Kusano *
K
KT Kaoru Takizawa
J
JK Jitsutaro Kawaguchi
I
IH Isamu Hara
T
TM Toyotaka Mori
DOI:10.3389/fgeed.2026.1718252delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Homologous recombination (HR) corrects a mutational sequence causing a genetic disease by replacing it with the normal sequence to restore a healthy state in humans. A targeted genomic breakage; such as that induced by CRISPR–Cas9; can trigger a copy-paste-type HR event; however; CRISPR–Cas9 more frequently induces imprecise non-homologous end-joining events; leading to one-step multiple knockout products for paralogous genes or homologous alleles; which can be considered a unique advantage. We have established a precision strategy for crossover-type HR-based gene editing; primed by intra-cellular circular donor cleavage (InCDC). The InCDC technique generates targeted duplication of the circular donor plasmid at the target locus in human cells; forming a doublet configuration comprising the donor DNA with the designed sequence and the target DNA with the original sequence; with much higher efficiency than conventional donor linearization techniques. This doublet form leads to the singlet form; resulting in retention of the designed allele. We found that the safety distance within the designed circular donor plasmid and its intra-cellular cleavage was particularly critical to protect a designed sequence from enzymatic exclusion; and we propose that InCDC technology enables precision genome editing; such as the replacement of a genetic disease-causing allele with the correctly designed allele.
Keywords:
crossover-type homologous recombination
intra-cellular circular donor cleavage
natural replacement
safety distance
targeted duplication
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

F
Frontiers in Genome Editing
IF:
4.4
Papers:
82
Citations:
893

Organization

I
id pharma co.
Scholars:
2
Papers: 1
Citations: 0
U
University of Tsukuba
Scholars:
1.8W
Papers: 1.5W
Citations: 1.7W
Cited Papers

Cited Papers

Citing Papers

Citing Papers